Using tDCS in Speech-based Stroke Rehabilitation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorNYU Langone Health

About this trial

The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants. tDCS provides low intensity neural stimulation which has been shown to facilitate motor learning in other domains of stroke rehabilitation such as arm motor learning but the potential to enhance speech motor learning has not been explored. This will be examined with a series of single-case experimental designs.

Eligibility criteria

Qualifiers

Right-handed

Monolingual (English)

Single left-hemisphere CVA

A minimum of six months post-stroke

Disqualifiers

Diagnosis of laryngeal voice disorder

Dysarthria

History of speech impairment prior to CVA

Presence of potential tDCS risk factors: damaged skin at site of stimulation;

Trial design

Treatments tested in this trial

  • Soterix 1x1 line tDCS low-intensity stimulator
  • Sham

Treatment groups

24 Participants
are divided into 2 treatment groups

Sponsors and collaborators

NYU Langone Health

Lead sponsor

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator